Articles tagged with Human Immunodeficiency Virus
Researchers used genome sequencing to detect rare viral mutations and found that low-frequency resistant HIV strains can lead to premature therapy failure. The study aimed to determine if patients who fail treatment early were initially infected with drug-resistant strains.
A retrospective study identified rare drug-resistant HIV variants in blood samples from an earlier clinical trial using ultra-deep sequencing. The findings suggest that even low-level mutations can lead to early treatment failure, highlighting the need for improved resistance testing methods.
A targeted approach to HIV testing and counseling is more effective in identifying people with HIV and preventing new infections. The study estimates that for the same cost, a targeted program could diagnose over three times as many people with HIV and prevent four times as many new infections compared to the CDC's mass testing plan.
Researchers at USU have developed a new HIV vaccine that induces broad-spectrum neutralizing antibodies, capable of neutralizing all 48 tested strains. The study provides encouraging results for vaccine development, showing the feasibility of eliciting cross-reactive antibodies against multiple viral strains.
Researchers at University of Toronto have discovered how HIV works to counteract the natural defense against malaria in pregnant women. The study found that HIV-infected women lose protective antibodies, making them susceptible to severe anaemia and infant deaths.
In conflict settings, HIV treatment can be effectively delivered with preparedness and contingency measures. A study from Médecins Sans Frontières (MSF) reports similar treatment outcomes to non-conflict settings, highlighting the importance of emergency drug supplies, stockpiling, and educating patients on consistent pill-taking. The ...
A new study found that flash-heating breast milk can successfully inactivate HIV, providing a safe alternative for mothers in resource-poor communities. The technique involves heating the milk in a pan of water over a flame and retains most of its nutritional and antimicrobial properties.
A university-based ED implemented opt-out HIV screening, with 60% of patients agreeing to testing. The study resulted in a low cost per preliminary positive ($1,700) and confirmed cases of HIV infection ($4,900).
A recent Dutch study found that drug users are becoming more cautious when using needles, mainly due to the effective HAART therapy introduced in 1996. This increased caution has led to a significant decrease in HIV and hepatitis C infections among drug users.
Researchers found that HIV patients with regular medical care have better survival rates compared to those without. The study, conducted on 2,619 men with HIV, showed that patients who visited their healthcare provider at least once each quarter had significantly lower risk of dying.
A new study by the Mailman School of PH found that marital sex is a single greatest risk for HIV infection among women worldwide. The study highlights the need for prevention programs that make extramarital sex safer rather than trying to eradicate it.
A new study by UCLA and Rand Corp. reveals that more than half of children with an HIV-infected parent are not consistently in that parent's custody. This finding can help physicians better address the needs of families affected by HIV.
Researchers explore how religious leaders and congregations respond to HIV/AIDS, with a focus on the impact on black church communities. The study aims to identify existing support groups and reveal how social networks can increase self-worth and prolong lives.
A new mouse model of HIV-related dementia shows that green tea extract EGCG reduces neurotoxicity of proteins secreted by HIV. The study suggests a potential natural compound for preventing and treating the devastating disease.
A community survey of gay men in London, Manchester, and Brighton found that nearly one-third of HIV-positive men reported having unprotected sex, while almost one-fifth of HIV-negative men also engaged in this behavior. The study highlights the need for renewed efforts to boost HIV diagnosis and curb risk behaviors.
The HIV Medicine Association strongly opposes The Gambia's use of an unproven herbal remedy for treating HIV/AIDS. The organization urges patients to resume taking their prescribed antiretroviral medications, which have been shown to save lives in Africa.
A recent study monitored the reproductive health of adolescent girls perinatally infected with HIV, revealing a higher than expected rate of cervical abnormalities. Nearly half of the girls had abnormal cervical cells, highlighting the need for targeted prevention strategies.
Researchers are exploring the effectiveness of telephone support groups for older adults with HIV. A new four-year study aims to test the benefits of this approach in treating depression and other mental health issues among seniors with HIV.
A natural ingredient in human blood has been identified as an effective blocker of HIV-1, the virus responsible for AIDS. The peptide, VIRIP, targets a conserved region in the viral envelope and remains effective against drug-resistant strains.
A new class of anti-HIV drugs has proven effective in a clinical trial by inhibiting the integrase enzyme, leading to a significant drop in HIV RNA levels and an increase in CD4 cells. The study suggests that this drug could become an important component of combination treatment regimens for heavily pretreated patients.
A new MUHC-led study reveals the oral fluid-based OraQuick HIV1/2 test to be 100% accurate and a patient-preferred choice for HIV testing in rural India. The test demonstrated higher accuracy than traditional blood tests, with minimal discomfort during sample collection.
A new antiretroviral drug darunavir has been shown to be highly effective in treating HIV when used in conjunction with a boosting dose of the existing drug ritonavir. The study found that 61% of patients taking the new drug achieved a ten-fold drop in HIV RNA levels, compared to just 15% of those on the control group.
Researchers at Thomas Jefferson University found that a weakened rabies virus can ferry HIV-related proteins into animals, vaccinating them against an AIDS-like disease. After two years of challenge with SIV/HIV viruses, vaccinated non-human primates showed protection from disease and high CD4 cell counts.
A RAND Corporation study reveals that people with stronger religious ties are less likely to spread HIV. The study found that moral beliefs and faith community membership may play a crucial role in reducing high-risk behaviors.
Research suggests that exclusive breastfeeding significantly lowers a baby's risk of postnatal infection with HIV. In contrast, introducing animal milks and solid foods before 14 weeks increases the risk. The study's findings warrant a revision of current infant-feeding guidelines.
A new study published in PLoS Medicine found that community-based peer education, free condom distribution, and clinic-based STI treatment services targeting high-risk individuals had no effect on HIV incidence in the wider community. However, these measures did reduce HIV-1 incidence among men who participated in the program.
A new study reveals that up to 1 in 10 infected infants may survive into late childhood or early adolescence without diagnosis or treatment. Late diagnosis can significantly affect their future health and long-term survival, emphasizing the need for accessible and sympathetic HIV testing and treatment services.
A new assay allows simultaneous detection of individual proteins and their interactions in living cells, enabling researchers to monitor protein expression and interaction networks. This breakthrough method has the potential to develop novel antiviral factors and therapies for infectious diseases and cancers.
A study published in The Journal of Infectious Diseases found that early HIV infections account for nearly half of all transmission occurrences. Early infection is characterized by a high viral load, making newly infected individuals highly infectious.
A study by UCLA researchers found that only 41% of primary care providers offered advice on sexually transmitted infections or safe sex, while 36% had offered more than 20 HIV tests. The study suggests that providers are testing patients who present with symptoms rather than proactively offering early detection.
A Johns Hopkins study reveals that entecavir can lead to cross-resistance with other antiviral drugs used to treat HIV. The findings have serious implications for co-infected patients who may not be aware of the risks.
Two trials found HIV acquisition rates to be 53% and 51% lower in circumcised men compared to uncircumcised men in Kenya and Uganda, respectively. The Lancet published the findings on adult male circumcision as a prevention strategy for HIV.
A clinical trial enrolling over 2,700 uncircumcised men found that circumcision reduced the risk of acquiring HIV by 53% compared to uncircumcised men. The study's results suggest that circumcision can be an effective addition to other prevention and reproductive health services in sub-Saharan Africa.
Data collected from voluntary HIV counselling and testing clinics in Africa are biased and unreliable, making them unsuitable for HIV surveillance. A better approach would be to use community-based surveys like Demographic and Health Surveys that inquire about testing history and sexual behavior.
Researchers have generated an atomic-level picture of a stable HIV surface protein component that appears vulnerable to attack from the b12 antibody. This finding could help develop an HIV vaccine capable of eliciting a robust antibody response.
QUT scientists have developed advanced ceramic membranes for nanofiltration that can remove viruses from water, air, and blood. The technology has the potential to filter out HIV from blood, saving millions of lives.
A mathematical model created by researchers shows that South African migration played a major role in the spread of HIV, increasing high-risk sexual behavior among migrant men and their partners. Without migration, peak HIV prevalence would be less than 5 percent.
In a randomized placebo-controlled trial, patients smoking cannabis experienced a 34 percent reduction in intense foot pain associated with HIV—twice the rate experienced by patients who smoked placebo. This study provides evidence for the therapeutic value of cannabis in managing HIV-associated sensory neuropathy.
A study of 32 African adolescents reveals long-standing HIV infection leads to stunted growth, chronic ill health and organ damage. Early testing and care can prevent this, highlighting the need for reduced barriers.
A new compound, 2-5AN6B, has shown significant promise in inhibiting HIV replication in white blood cells from HIV-infected patients. The compound works by a different mechanism than current drugs, reducing the risk of mutation and improving treatment effectiveness.
A Johns Hopkins study found that 31% of HIV-positive patients in Uganda had HIV dementia, a rate that challenges Alzheimer's and stroke dementia globally. The condition is treatable and potentially reversible with antiretroviral medication.
A study found that selenium supplements increased blood selenium levels and suppressed HIV viral load in patients with HIV. The results suggest that selenium may be a safe and inexpensive adjunct therapy to conventional pharmacotherapy.
A review of government policy is needed to increase HIV testing uptake in the UK. Lucy Frith argues that new technologies, antiretroviral therapy, and patient autonomy make self-testing safer and more effective.
A new UCLA study warns that the World Health Organization's (WHO) plan to track transmitted HIV drug resistance in Botswana may not be effective due to a high detection threshold. The researchers suggest revising the threshold to around 3 percent to detect resistance earlier and provide more accurate information on the situation in Bot...
Researchers at Princeton University have found a specific genetic trigger that can deactivate the HIV virus, potentially leading to new treatments. The trigger, involving an enzyme called SirT1, can keep the virus in its dormant phase, reducing its ability to replicate.
Researchers found that starting HIV treatment at least six months after a single dose of nevirapine during labor improves response rates. Women who started treatment sooner had reduced effectiveness of ART, while those delayed had comparable outcomes to placebo group.
Researchers developed a sensitive test for identifying drug-resistant strains of HIV in patients' bloodstreams. The test detects genetic changes that predict potential drug resistance, enabling personalized treatment guidance.
A new study proposes that HIV regulates latency by introducing a resistor into its main transcriptional activator, Tat. The model suggests that this simple switch acts as a 'feedback resistor' to prevent stray transcription and maintain dormancy.
Research reveals that nearly one-fourth of people with HIV have metabolic syndrome, characterized by low HDL cholesterol and hypertriglyceridemia. HAART users also show increased risk for components of metabolic syndrome, highlighting the need for healthcare providers to monitor risk factors.
Recent studies have made significant advancements in understanding HIV, bacterial quorum sensing, and cancer treatment. Researchers have discovered innovative strategies to combat HIV resistance and develop novel genetic circuits for industrial applications.
A study of 332 HIV-infected patients found that those with high viral loads were at increased risk of surgical complications, including pneumonia. The researchers also found that patients with low CD4 cell counts had more complications than those with higher counts.
A study published in Nature Medicine found that targeting specific HIV proteins can lead to effective control of the virus. Researchers suggest that a more targeted vaccine approach may be necessary.
A randomized controlled trial conducted in Kenya demonstrates that male circumcision significantly reduces the risk of acquiring HIV, with a 53% reduction in new infections among circumcised men. The study, funded by CIHR, provides conclusive evidence supporting the use of circumcision as an important HIV prevention strategy.
A new study published in BMC Medicine found that HIV prevalence in Andhra Pradesh's Guntur district is 1.72%, significantly lower than the official estimate of 4.3% for the entire country. The study estimated 45,900 individuals with HIV in Guntur district, highlighting potential overestimation of HIV burden in India.
A new study by researchers at Fred Hutchinson Cancer Center and the University of Washington found that malaria increases HIV transmission to sex partners by up to 10 times. HIV-infected individuals are also more susceptible to malaria infections due to their compromised immune systems, fueling a rise in adult malaria-infection rates.
Researchers found that HIV-1 infection leads to the loss of immune cells in the gut, which may never return to normal levels. A subset of patients showed only half the normal number of CD4+ effector memory T cells in their GI tracts despite effective antiretroviral therapy.
A study of 119 physician groups found that integrated medical groups delivered higher quality care on four of six measures than individual practice associations. Routine, voluntary rapid HIV testing for all adults, except those with low prevalence, is cost-effective and supported by the CDC recommendation.
A recent study by researchers at Yale University found that routine HIV screening in virtually all health settings is cost-effective and saves lives. The study provides strong support for the US CDC guidelines recommending HIV screening of all persons aged 13-64 in all healthcare settings.
A new approach to HIV prevention focuses on reducing partners, with early evidence from Uganda and Kenya showing a decline in HIV incidence among men. The strategy is seen as a crucial step towards reversing the epidemic, particularly in regions where partner reduction has been successful.
A systematic review of HIV medication adherence factors reveals common barriers in both developed and developing countries, as well as unique challenges in resource-constrained settings. Facilitators of adherence include having a sense of self-worth, simplicity of regimens, and reminder tools, but no such facilitators were identified i...